Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease

Research paper produced as a result of multi-disciplinary (Physiotherapy, Dietetics, Medicine) collaboration with the Centre for Systems Biology and Medicine, University of Nottingham (Sigrist, PhD candidate)Background. Chronic renal replacement therapy patients exhibit reduction in skeletal muscle function as a result of a combination of metabolic effects and muscle fibre size reduction. The aim of this study was to compare muscle mass with function in patients with chronic kidney disease (CKD) at stages 4 and 5 on haemodialysis (HD) and peritoneal dialysis (PD), and investigate the associations of muscle wasting in a cross-sectional cohort. Methods. We studied 134 patients (60 HD, 28 PD and 46 CKD 4). The three groups were well matched for age, sex, diabetes and dialysis vintage. Cross-sectional area (CSA) of muscle and fat was measured from a standardized multi-slice CT scan of a 6 cm long section of thigh. CSA of soft tissue was taken from appropriate fat and muscle densities. Functional assessment was by the sit-to-stand 60 test, assessing both the number of sit-to-stands possible under controlled conditions in 60 s (STS 60), and the time taken to perform five sit-to-stand movements (STS 5). Data were collected on a wide range of potential determinants of muscle CSA. Results. There were no significant differences in haemoglobin between males or females or between any of the groups studied. Serum phosphate and calcium-phosphate product were higher in HD patients as compared to CKD4 patients, but there were no differences in these variables when comparing PD patients with either CKD4 or HD patients. Muscle CSA correlated well with objective functional assessments in males (STS 60 R = 0.52, P<0.0001) and females (R = 0.41, P = 0.004), and STS performance was reduced in dialysed patients as compared with CKD 4. Univariate analysis demonstrated that muscle CSA was associated with serum albumin concentration (R = 0.49, P<0.0001), age (R = -0.35, P = 0.005) and C-reactive protein (R = -0.34, P = 0.004). Creatinine clearance, dialysis adequacy, dialysis vintage and time-averaged serum bicarbonate, calcium and phosphate concentrations were not correlated with muscle CSA. Conclusion. In conclusion, patients with dialysis-treated CKD 5 exhibited more functionally significant muscle wasting than patients with CKD 4. This may be amenable to modification with targeted exercise or amelioration of factors associated with observed differences in muscle masssch_phyJohansen K, Shubert T, Doyle J et al. Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality and physical function. Kidney Int 2003; 63: 291-297[CrossRef][ISI][Medline] Ohkawa S, Odamaki M, Yoneyama T et al. Standaradised thigh muscle area measured by computed axial tomography as an alternate muscle mass index for nutritional assessment of hemodialysis patients. Am J Clin Nutr 2000; 71: 485-490[Abstract/Free Full Text] Beasley C, Smith D, Neale T. Exercise capacity in chronic renal failure patients managed by continuous ambulatory peritoneal dialysis. Aust NZ J Med 1986; 16: 5-10[ISI][Medline] DeOreo P. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalisation and dialysis attendance compliance. Am J Kidney Dis 1997; 30: 204-212[ISI][Medline] Kouidi E, Albani M, Natkis K et al. The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dialysis Transplant 1998; 13: 685-699[Abstract/Free Full Text] Sakkas G, Ball D, Mercer T et al. Atrophy of non-locomotor muscle in patients with end-stage renal failure. Nephrol Dialysis Transplant 2003; 18: 2074-2081[Abstract/Free Full Text] Kaizu Y, Ohkawa S, Odamaki M et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis 2003; 42: 295-302[CrossRef][ISI][Medline] Bergstrom J. Nutrition and mortality in hemodialysis. J Am Soc Nephrol 1995; 6: 1329-1341[Abstract] Macdonald J, Phanish M, Marcora S et al. Muscle insulin-like growth factor status, body composition and functional capacity in hemodialysis patients. J Ren Nutr 2004; 14: 248-252[ISI][Medline] Mitsiopolous N, Baumgartner R, Heymsfield S et al. Cadaver validation of skeletal muscle mass measurement by magnetic resonance imaging and computarized tomography. J Appl Physiol 1998; 85: 115-122[Abstract/Free Full Text] Diesel W, Knight B, Noakes T et al. Morphologic features of myopathy associated with chronic renal failure. Am J Kid Dis 1993; 22: 677-684[ISI][Medline] Sakkas G, Ball D, Sargeant A et al. Skeletal muscle morphology and capillarization of renal failure patients receiving different dialysis therapies. Clin Sci (Lon) 2004; 107: 617-623 Blake C, O'Meara Y. Subjective and objective physical limitations in high-functioning renal dialysis patients. Nephrol Dialysis Transplant 2004; 19: 3124-3129[Abstract/Free Full Text] Guralnik J, Ferruci L, Pieper C et al. Lower extremity function and subsequent disability: consistency across studies, predictive models and value of gait speed alone compared with short physical performance battery. J Gerontol A Biol Sci Med 2000; 55: M221-M231[Abstract/Free Full Text] Ohkawa S,Odamaki M, Ikegaya N et al. Association of age with muscle mass, fat mass and fat distribution in non-diabetic haemodialysis patients. Nephrol Dialysis Transplant 2005; 20: 945-951[Abstract/Free Full Text] Woodrow G, Oldroyd D, Turney J et al. Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorpiometry. Eur J Clin Nutr 1996; 50: 295-301[ISI][Medline] Adey D, Kumar R, McCarthy J et al. Reduced synthesis of muscle proteins in chronic renal failure. Am J Endocrinol Metab 2000; 278: 219-225 Caso G, Garlick P. Control of muscle protein kinetics by acid-base balance. Curr Opin Clin Nutr Metab Care 2005; 8: 73-76[ISI][Medline] Young G, Kopple J, Lindholm B et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991; 17: 462-471[ISI][Medline] Kaysen G, Eiserich J. Characteristics and effects of inflammation in end-stage renal disease. Semin Dial 2003; 16: 438-446[CrossRef][ISI][Medline] McIntyre C, Harper L, Mcdougal IC et al. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clinical Nephrology 1997; 46: 371-37421pub96pub